Cargando…
Ductal Adenocarcinoma Ex Pleomorphic Adenoma of the Lacrimal Gland: a Rare and Morbid Malignancy
Carcinoma ex pleomorphic adenoma (Ca ex PA) is a rare malignant transformation of a benign primary pleomorphic adenoma (PA). We report the case of a 62-year-old male who presented with a swelling over his left temple. Imaging revealed a lytic lesion over the left orbital wall with soft tissue extens...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7021468/ https://www.ncbi.nlm.nih.gov/pubmed/32089922 http://dx.doi.org/10.1155/2020/1790106 |
_version_ | 1783497882602569728 |
---|---|
author | Ashok Kumar, Prashanth Paulraj, Shweta Mirchia, Kanish Hahn, Seung Shin Sivapiragasam, Abirami |
author_facet | Ashok Kumar, Prashanth Paulraj, Shweta Mirchia, Kanish Hahn, Seung Shin Sivapiragasam, Abirami |
author_sort | Ashok Kumar, Prashanth |
collection | PubMed |
description | Carcinoma ex pleomorphic adenoma (Ca ex PA) is a rare malignant transformation of a benign primary pleomorphic adenoma (PA). We report the case of a 62-year-old male who presented with a swelling over his left temple. Imaging revealed a lytic lesion over the left orbital wall with soft tissue extension suggestive of malignancy. He underwent an en bloc resection of the mass with orbital exenteration, craniotomy, and reconstruction. Pathology demonstrated a lacrimal gland ductal adenocarcinoma arising from a PA which led to the diagnosis of ductal adenoCa ex PA. Postoperatively, he received chemotherapy with 6 cycles of cisplatin and concurrent radiation therapy (RT), but his course was complicated by recurrent bacterial meningitis and abscesses and he ultimately opted for comfort measures. Patients with PA of the lacrimal gland experience an insidiously enlarging painless swelling of the orbit with transformation to Ca ex PA highlighted by a rapid onset of bulbar enlargement, displacement, and often proptosis. Ductal adenoCa ex PA is aggressive with a poor prognosis and has no established standard of care. This case highlights the rarity of this condition and the need for more literature to help direct treatment. |
format | Online Article Text |
id | pubmed-7021468 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-70214682020-02-21 Ductal Adenocarcinoma Ex Pleomorphic Adenoma of the Lacrimal Gland: a Rare and Morbid Malignancy Ashok Kumar, Prashanth Paulraj, Shweta Mirchia, Kanish Hahn, Seung Shin Sivapiragasam, Abirami Case Rep Oncol Med Case Report Carcinoma ex pleomorphic adenoma (Ca ex PA) is a rare malignant transformation of a benign primary pleomorphic adenoma (PA). We report the case of a 62-year-old male who presented with a swelling over his left temple. Imaging revealed a lytic lesion over the left orbital wall with soft tissue extension suggestive of malignancy. He underwent an en bloc resection of the mass with orbital exenteration, craniotomy, and reconstruction. Pathology demonstrated a lacrimal gland ductal adenocarcinoma arising from a PA which led to the diagnosis of ductal adenoCa ex PA. Postoperatively, he received chemotherapy with 6 cycles of cisplatin and concurrent radiation therapy (RT), but his course was complicated by recurrent bacterial meningitis and abscesses and he ultimately opted for comfort measures. Patients with PA of the lacrimal gland experience an insidiously enlarging painless swelling of the orbit with transformation to Ca ex PA highlighted by a rapid onset of bulbar enlargement, displacement, and often proptosis. Ductal adenoCa ex PA is aggressive with a poor prognosis and has no established standard of care. This case highlights the rarity of this condition and the need for more literature to help direct treatment. Hindawi 2020-02-03 /pmc/articles/PMC7021468/ /pubmed/32089922 http://dx.doi.org/10.1155/2020/1790106 Text en Copyright © 2020 Prashanth Ashok Kumar et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Ashok Kumar, Prashanth Paulraj, Shweta Mirchia, Kanish Hahn, Seung Shin Sivapiragasam, Abirami Ductal Adenocarcinoma Ex Pleomorphic Adenoma of the Lacrimal Gland: a Rare and Morbid Malignancy |
title | Ductal Adenocarcinoma Ex Pleomorphic Adenoma of the Lacrimal Gland: a Rare and Morbid Malignancy |
title_full | Ductal Adenocarcinoma Ex Pleomorphic Adenoma of the Lacrimal Gland: a Rare and Morbid Malignancy |
title_fullStr | Ductal Adenocarcinoma Ex Pleomorphic Adenoma of the Lacrimal Gland: a Rare and Morbid Malignancy |
title_full_unstemmed | Ductal Adenocarcinoma Ex Pleomorphic Adenoma of the Lacrimal Gland: a Rare and Morbid Malignancy |
title_short | Ductal Adenocarcinoma Ex Pleomorphic Adenoma of the Lacrimal Gland: a Rare and Morbid Malignancy |
title_sort | ductal adenocarcinoma ex pleomorphic adenoma of the lacrimal gland: a rare and morbid malignancy |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7021468/ https://www.ncbi.nlm.nih.gov/pubmed/32089922 http://dx.doi.org/10.1155/2020/1790106 |
work_keys_str_mv | AT ashokkumarprashanth ductaladenocarcinomaexpleomorphicadenomaofthelacrimalglandarareandmorbidmalignancy AT paulrajshweta ductaladenocarcinomaexpleomorphicadenomaofthelacrimalglandarareandmorbidmalignancy AT mirchiakanish ductaladenocarcinomaexpleomorphicadenomaofthelacrimalglandarareandmorbidmalignancy AT hahnseungshin ductaladenocarcinomaexpleomorphicadenomaofthelacrimalglandarareandmorbidmalignancy AT sivapiragasamabirami ductaladenocarcinomaexpleomorphicadenomaofthelacrimalglandarareandmorbidmalignancy |